A subcommittee of the House Energy and Commerce (E&C) Committee, which is tasked with overseeing the 340B drug discount program, [...] …
Year: 2024
The Rhode Island Senate yesterday approved legislation that would prohibit 340B contract pharmacy restrictions in that state, sending it to [...] …
SPONSORED CONTENT
The 340B program remains essential in ensuring equitable access to crucial medications for vulnerable, underserved populations. The program provides safety net providers with critical resources necessary to expand health related services to low-income and uninsured individuals. Over the past decade, controversy,
…
The New Hampshire House cleared a bill last week to prohibit certain 340B-specific pharmacy benefit manager (PBM) and health insurer [...] …
Ohio Community Health Center CEOs, Lawmakers Urge Passage of State Contract Pharmacy Protection Bill
Ohio federally qualified health center (FQHC) leaders called on state lawmakers Tuesday to pass newly introduced legislation that would end [...] …
Congress’ in-house non-partisan research arm recently produced a summary of the range of policy actions affecting 340B contract pharmacy use [...] …
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...] …
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...] …
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program based on recommendations from a nonprofit group [...] …
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …